Masimo Corp's (MASI) Radius-7 Receives FDA 510(k) Clearance

by StreetInsider.com

Masimo (NASDAQ: MASI) today announced FDA 510(k) clearance of Radius-7" for the Root patient monitoring and connectivity platform, the first and only wearable, wireless monitor with Masimo's breakthroughrainbow SET technology, offering patients continuous monitoring with freedom of movement.

With rainbow SET noninvasive measurements, Radius-7 with Root can alert clinicians -- at the bedside or remotely, through theMasimo Patient SafetyNet" remote monitoring and notification system -- of critical changes in a patient's oxygen saturation and pulse rate -- even during states of motion and low perfusion -- as well as respiration through acoustic respiration rate (RRa). 

See the full article here.

Search kBLASTER for FDA 510(k) predicates with effective result management to build your successful 510(k) clearance strategy.